A detailed history of Swiss National Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Swiss National Bank holds 5,240,910 shares of ABBV stock, worth $927 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
5,240,910
Previous 5,242,510 0.03%
Holding current value
$927 Million
Previous $899 Million 15.1%
% of portfolio
0.69%
Previous 0.63%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$163.84 - $199.33 $262,144 - $318,928
-1,600 Reduced 0.03%
5,240,910 $1.03 Billion
Q2 2024

Aug 08, 2024

SELL
$154.79 - $180.76 $6.93 Million - $8.1 Million
-44,800 Reduced 0.85%
5,242,510 $899 Million
Q1 2024

May 07, 2024

SELL
$159.82 - $182.1 $37.1 Million - $42.2 Million
-231,900 Reduced 4.2%
5,287,310 $963 Million
Q4 2023

Feb 06, 2024

SELL
$137.6 - $154.97 $21.4 Million - $24.1 Million
-155,600 Reduced 2.74%
5,519,210 $855 Million
Q3 2023

Nov 08, 2023

SELL
$133.59 - $154.65 $93.1 Million - $108 Million
-696,600 Reduced 10.93%
5,674,810 $846 Million
Q2 2023

Aug 09, 2023

SELL
$132.51 - $164.9 $85.7 Million - $107 Million
-647,000 Reduced 9.22%
6,371,410 $858 Million
Q1 2023

May 10, 2023

SELL
$144.61 - $166.54 $24.2 Million - $27.9 Million
-167,600 Reduced 2.33%
7,018,410 $1.12 Billion
Q4 2022

Feb 08, 2023

SELL
$138.31 - $165.87 $65.3 Million - $78.4 Million
-472,365 Reduced 6.17%
7,186,010 $1.16 Billion
Q3 2022

Nov 09, 2022

SELL
$134.21 - $153.93 $1.92 Million - $2.2 Million
-14,300 Reduced 0.19%
7,658,375 $1.03 Billion
Q2 2022

Aug 09, 2022

BUY
$137.62 - $174.96 $2.13 Million - $2.71 Million
15,500 Added 0.2%
7,672,675 $1.18 Billion
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $124 Million - $154 Million
940,300 Added 14.0%
7,657,175 $1.24 Billion
Q4 2021

Feb 08, 2022

SELL
$107.43 - $135.93 $28.7 Million - $36.3 Million
-266,900 Reduced 3.82%
6,716,875 $909 Million
Q3 2021

Nov 08, 2021

SELL
$106.4 - $120.78 $23.1 Million - $26.2 Million
-216,800 Reduced 3.01%
6,983,775 $753 Million
Q2 2021

Aug 06, 2021

BUY
$105.21 - $117.21 $43.2 Million - $48.2 Million
410,984 Added 6.05%
7,200,575 $811 Million
Q1 2021

May 07, 2021

BUY
$102.3 - $112.62 $12.8 Million - $14.1 Million
125,400 Added 1.88%
6,789,591 $735 Million
Q4 2020

Feb 05, 2021

SELL
$80.49 - $108.67 $17 Million - $22.9 Million
-210,700 Reduced 3.06%
6,664,191 $714 Million
Q3 2020

Nov 09, 2020

SELL
$85.91 - $100.83 $9.48 Million - $11.1 Million
-110,400 Reduced 1.58%
6,874,891 $602 Million
Q2 2020

Aug 05, 2020

BUY
$73.37 - $98.18 $91.4 Million - $122 Million
1,245,930 Added 21.71%
6,985,291 $686 Million
Q1 2020

May 08, 2020

BUY
$64.5 - $97.79 $69.5 Million - $105 Million
1,077,400 Added 23.11%
5,739,361 $437 Million
Q4 2019

Feb 06, 2020

SELL
$72.13 - $90.25 $15.9 Million - $19.9 Million
-220,100 Reduced 4.51%
4,661,961 $413 Million
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $4.61 Million - $5.55 Million
73,232 Added 1.52%
4,882,061 $370 Million
Q2 2019

Aug 02, 2019

SELL
$65.7 - $83.98 $13.9 Million - $17.8 Million
-212,200 Reduced 4.23%
4,808,829 $350 Million
Q1 2019

May 10, 2019

BUY
$77.14 - $90.79 $7.59 Million - $8.93 Million
98,400 Added 2.0%
5,021,029 $405 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $6.34 Million - $7.82 Million
81,400 Added 1.68%
4,922,629 $454 Million
Q3 2018

Nov 08, 2018

SELL
$88.91 - $98.84 $18.6 Million - $20.7 Million
-209,000 Reduced 4.14%
4,841,229 $458 Million
Q2 2018

Aug 09, 2018

SELL
$89.78 - $106.23 $6.44 Million - $7.62 Million
-71,700 Reduced 1.4%
5,050,229 $468 Million
Q1 2018

May 04, 2018

SELL
$92.01 - $123.21 $69.8 Million - $93.4 Million
-758,100 Reduced 12.89%
5,121,929 $485 Million
Q4 2017

Feb 07, 2018

BUY
$89.56 - $98.21 $868,732 - $952,636
9,700 Added 0.17%
5,880,029 $569 Million
Q3 2017

Nov 03, 2017

BUY
$69.85 - $89.22 $410 Million - $524 Million
5,870,329
5,870,329 $522 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.